Determination of Plasma Heparin Level Improves Identification of Systemic Mast Cell Activation Disease

Diagnosis of mast cell activation disease (MCAD), i.e. systemic mastocytosis (SM) and idiopathic systemic mast cell activation syndrome (MCAS), usually requires demonstration of increased mast cell (MC) mediator release. Since only a few MC mediators are currently established as biomarkers of MCAD,...

Descripción completa

Detalles Bibliográficos
Autores principales: Vysniauskaite, Milda, Hertfelder, Hans-Jörg, Oldenburg, Johannes, Dreßen, Peter, Brettner, Stefan, Homann, Jürgen, Molderings, Gerhard J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409380/
https://www.ncbi.nlm.nih.gov/pubmed/25909362
http://dx.doi.org/10.1371/journal.pone.0124912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409380/
https://www.ncbi.nlm.nih.gov/pubmed/25909362
http://dx.doi.org/10.1371/journal.pone.0124912

Ejemplares similares